Definium Therapeutics, Inc. (DFTX) Stock

NASDAQ: DFTXHealthcare company in the biotechnology industry, based in New York, NY.

Definium Therapeutics stock price chart

DFTX stock quote & key statistics

Definium Therapeutics earnings per share

Earnings per share

Definium Therapeutics revenue & net income

RevenueNet income

Definium Therapeutics annual financials

Fiscal yearRevenueNet incomeEPS
FY2025$0-$183.8M-$2.08
FY2024$0-$108.7M-$2.02
FY2023$0-$95.7M-$4.30
FY2022$0-$56.8M-$1.89
FY2021$0-$93.0M-$5.36

Fiscal year ending December 31. Source: company filings via EODHD.

About Definium Therapeutics, Inc.

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder.

The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.

Definium Therapeutics stock FAQ

What is the Definium Therapeutics stock ticker symbol?

Definium Therapeutics, Inc. trades on the NASDAQ under the ticker symbol DFTX.

What sector and industry is Definium Therapeutics in?

Definium Therapeutics, Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Definium Therapeutics have?

Definium Therapeutics, Inc. has about 105 full-time employees.

What were Definium Therapeutics's revenue and earnings last fiscal year?

Definium Therapeutics reported revenue of $0 and net income of -$183.8M in fiscal 2025, with earnings per share of -$2.08.

Is Definium Therapeutics in the Russell 2000?

Yes. Definium Therapeutics, Inc. (DFTX) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did Definium Therapeutics go public?

Definium Therapeutics stock began trading on July 11, 2022.

Russell 2000 Biotechnology stocks

All Russell 2000 →